Cheilectomy Market Research Report – Global Forecast till 2027

Global cheilectomy market research report: by method (open, arthroscopic, percutaneous) anesthesia (general, local, and regional anesthesia) medication (prescription pain relievers, NSAIDs) end-users (academic institutes, clinics) – Forecast till 2027

ID: MRFR/Pharma/4024-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


Cheilectomy is a surgical procedure aimed to remove the bony lump present on the top of the metatarsophalangeal joint (big toe). Hallux rigidus, a type of big toe arthritis is a major cause of the same. According to a study published in the World Journal of Orthopedics in 2017, hallux rigidus is a degenerative disease of the first MTP joint. Moreover, it is estimated that the disease affects 1 in every 40 people, aged 50 or more. Females are greatly affected by the disease as compared to males, .i.e., by a ratio of 2:1.  Therefore, increasing prevalence of hallux rigidus and growing female population are the major drivers for the market growth during the forecast period. Additionally, increasing demands for minimally invasive procedures and rising healthcare expenditure is estimated to fuel the market. According to the World Health Organization, the geriatric population is projected to grow from an estimated 524 million in 2010 to approximately 1.5 billion by 2050. However, high procedural cost followed by complications like deep vein thrombosis, need for repeated surgery, stiffness in the joints of the toes and low per capita healthcare expenditure in the middle and low-income countries is estimated to restrain the market growth during the projected period. According to the Fairfield Independent Hospital, the procedural cost for the same in 2016 was estimated to be around USD 3,545.


The global cheilectomy market is expected to grow at a CAGR of 7.8% during the forecast period.


Intended Audience



  • Pharmaceutical Companies

  • Biotechnological Institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Figure 1:- Global Cheilectomy Market Share, by Region


 Cheilectomy


Sources: WHO, annual reports, press release, white paper, and company presentation


 Segmentation:


The global cheilectomy market is segmented by the method, anesthesia, medication, and end-user.


By the method, the market is segmented into open, arthroscopic, and percutaneous method.


By the anesthesia, the market is categorized into general anesthesia, local anesthesia, and regional anesthesia. By the medication, the market is segmented into prescription pain relievers, OCT, and others. By prescription the pain relievers the market is segmented into corticosteroids, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is segmented into ibuprofen, naproxen, and others. By end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.


Regional Analysis:


The Americas dominate the global cheilectomy market owing to a well-developed healthcare sector and increasing the prevalence of hallux rigidus. Moreover, increasing healthcare expenditure and presence of the key players within the regions boosts the growth of the market in the Americas. Additionally, increasing geriatric population and growing female population fuels the regional market growth.


Europe is the second largest cheilectomy market, which is followed by Asia Pacific. Osteoarthritis is a common condition that may lead to hallux rigidus. Thus, increasing prevalence of the disease within the region drives the market growth. According to the Arthritis Research U.K in 2013, osteoarthritis was estimated to be the most common musculoskeletal condition in the geriatric population. Additionally, it was estimated that approximately, 8.75 million people within the region had sought some treatment for osteoarthritis.


Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India & China, and presence of huge opportunity in the market.


On the other hand, the Middle East & Africa has the least share in the global cheilectomy market due to the presence of poor economy, especially in the Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.


Research Methodology


 Cheilectomy 1


Sources: WHO, annual reports, press release, white paper, and company presentation


 Key players in global cheilectomy market


The key players for the global cheilectomy market are Henry Schein, Inc. (U.S.), STEROID S.p.A. (Italy), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium), PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim International GmbH (Germany), and others.



Frequently Asked Questions (FAQ) :


Cheilectomy market is projected to grow at approximately 7.8 % CAGR during the assessment period (2020-2027).

Increasing prevalence of hallux rigidus among female population and rising demands for minimally invasive procedures are the major tailwinds pushing the growth of the global cheilectomy market.

High procedural cost and complications such as deep vein thrombosis, need for repeated surgery, and stiffness in the joints of the toes are major growth impeders for the global cheilectomy market.

North America holds the largest share in the global cheilectomy market, followed by Europe and the Asia Pacific, respectively.

STEROID S.p.A. (Italy), Henry Schein, Inc. (U.S.), Pfizer Inc. (U.S.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Sanofi (France), PurduePharma (U.S.), Janssen Pharmaceuticals, Inc. (Belgium), ALLERGAN (Republic of Ireland), and Boehringer Ingelheim International GmbH (Germany), are some of the top players operating in the global cheilectomy market.

TABLE OF CONTENT


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Cheilectomy Market, by Method

6.1 Introduction

6.2 Open

Market Estimates & Forecast, 2020 – 2027

6.3 Arthroscopic

Market Estimates & Forecast, 2020 – 2027

6.4 Percutaneous

Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Cheilectomy Market, by Anesthesia

7.1 Introduction

7.2 General Anesthesia

Market Estimates & Forecast, 2020 – 2027

7.3 Local Anesthesia

Market Estimates & Forecast, 2020 – 2027

7.4 Regional Anesthesia

Market Estimates & Forecast, 2020 – 2027

7.5 Others

Chapter 8. Global Cheilectomy Market, by Medication

8.1 Introduction

8.2 Prescription Pain Relievers

Market Estimates & Forecast, 2020 – 2027

8.2.1 Corticosteroids

8.2.2 Opioids

8.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

8.2.4 Others

8.3 OTC Drugs

Market Estimates & Forecast, 2020 – 2027

8.3.1 Ibuprofen

8.3.2 Naproxen

8.3.3 Others

Chapter 9 Global Cheilectomy Market, by End User

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, 2020 – 2027

9.3 Academic Institutes

Market Estimates & Forecast, 2020 – 2027

9.4 Retail Pharmacies

Market Estimates & Forecast, 2020 – 2027

9.5 Others

Chapter 10. Global Cheilectomy Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Henry Schein, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 STEROID S.p.A.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Pfizer Inc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Novartis AG

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Abbott

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Merck & Co., Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Janssen Pharmaceuticals, Inc.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 PurduePharma

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 ALLERGAN

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Boehringer Ingelheim International GmbH

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Cheilectomy Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Cheilectomy Industry Synopsis, 2020 – 2027

Table 2 Global Cheilectomy Market Estimates and Forecast, 2020 – 2027, (USD Million)

Table 3 Global Cheilectomy Market by Region, 2020 – 2027, (USD Million)

Table 4 Global Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

Table 5 Global Cheilectomy Market by Anaesthesia, 2020 – 2027, (USD Million)

Table 6 Global Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

Table 7 Global Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

Table 8 North America Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

Table 9 North America Cheilectomy Market by Anaesthesia, 2020 – 2027, (USD Million)

Table 10 North America Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

Table 11 North America Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

Table 12 U.S. Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

Table 13 U.S. Cheilectomy Market by Anaesthesia, 2020 – 2027, (USD Million)

Table 14 U.S. Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

Table 15 U.S. Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

Table 16 Canada Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

Table 17 Canada Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

Table 18 Canada Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

Table 19 Canada Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

Table 20 South America Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

Table 21 South America Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

Table 22 South America Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

Table 23 South America Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

Table 24 Europe Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

Table 25 Europe Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

Table 26 Europe Cheilectomy Market by, Medication, 2020 – 2027, (USD Million)

Table 27 Europe Cheilectomy Market by, End Users, 2020 – 2027, (USD Million)

Table 28 Western Europe Cheilectomy Market by, Methods, 2020 – 2027, (USD Million)

Table 29 Western Europe Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

Table 30 Western Europe Cheilectomy Market by, Medication, 2020 – 2027, (USD Million)

Table 31 Western Europe Cheilectomy Market by, End Users, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Cheilectomy Market by, Methods, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

Table 34 Eastern Europe Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Cheilectomy Market by, Methods, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

Table 38 Asia Pacific Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

Table 40 Middle East & Africa Cheilectomy Market by Methods, 2020 – 2027, (USD Million)

Table 41 Middle East & Africa Cheilectomy Market by, Anaesthesia, 2020 – 2027, (USD Million)

Table 42 Middle East & Africa Cheilectomy Market by Medication, 2020 – 2027, (USD Million)

Table 43 Middle East & Africa Cheilectomy Market by End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Cheilectomy Market

Figure 3 Segmentation Market Dynamics for Global Cheilectomy Market

Figure 4 Global Cheilectomy Market Share, by Methods, 2020

Figure 5 Global Cheilectomy Market Share, by Anesthesia, 2020

Figure 6 Global Cheilectomy Market Share, by Medication 2020

Figure 7 Global Cheilectomy Market Share, by End Users, 2020

Figure 8 Global Cheilectomy Market Share, by Region, 2020

Figure 9 North America Cheilectomy Market Share, by Country, 2020

Figure 10 Europe Cheilectomy Market Share, by Country, 2020

Figure 11 Asia Pacific Cheilectomy Market Share, by Country, 2020

Figure 12 Middle East & Africa Cheilectomy Market Share, by Country, 2020

Figure 13 Global Cheilectomy Market: Company Share Analysis, 2020 (%)

Figure 14 Henry Schein, Inc.: Key Financials

Figure 15 Henry Schein, Inc.: Segmental Revenue

Figure 16 Henry Schein, Inc.: Geographical Revenue

Figure 17 STEROID S.p.A.: Key Financials

Figure 18 STEROID S.p.A.: Segmental Revenue

Figure 19 STEROID S.p.A.: Geographical Revenue

Figure 20 Pfizer Inc. : Key Financials

Figure 21 Pfizer Inc.: Segmental Revenue

Figure 22 Pfizer Inc.: Geographical Revenue

Figure 23 Abbott: Key Financials

Figure 24 Abbott: Segmental Revenue

Figure 25 Abbot: Geographical Revenue

Figure 26 Merck & Co., Inc.: Key Financials

Figure 27 Merck & Co., Inc.: Segmental Revenue

Figure 28 Merck & Co., Inc.: Geographical Revenue

Figure 29 Janssen Pharmaceuticals, Inc.: Key Financials

Figure 30 Janssen Pharmaceuticals, Inc.: Segmental Revenue

Figure 31 Janssen Pharmaceuticals, Inc.: Geographical Revenue

Figure 32 Novartis AG: Key Financials

Figure 33 Novartis AG: Segmental Revenue

Figure 34 Novartis AG: Geographical Revenue

Figure 35 PurduePharma: Key Financials

Figure 36 PurduePharma: Segmental Revenue

Figure 37 PurduePharma: Geographical Revenue

Figure 38 ALLERGAN: Key Financials

Figure 39 ALLERGAN: Segmental Revenue

Figure 40 ALLERGAN: Geographical Revenue

Figure 41 Boehringer Ingelheim International GmbH: Key Financials

Figure 42 Boehringer Ingelheim International GmbH: Segmental Revenue

Figure 43 Boehringer Ingelheim International GmbH: Geographical Revenue